Evaluation of antioxidant and anti-mutagenic activity of naturally fortified honey with Curcuma longa extract

Paper Details

Research Paper 01/07/2018
Views (251) Download (8)

Evaluation of antioxidant and anti-mutagenic activity of naturally fortified honey with Curcuma longa extract

Sundus Hameed Ahmed
Int. J. Biosci.13( 1), 247-255, July 2018.
Certificate: IJB 2018 [Generate Certificate]


Honey considered as natural product, also it has a great influence on health and can be used as antibacterial, anti-inflammation and antioxidant as wellndue to exiciting of some organic materials like amino acids, enzymes, peroxide and much more. The current research planned to explore the activity to anti-mutagenic and anti-oxidant to naturally fortified honey with Curcuma longa extract. The fortified honey   was evaluated by GC MASS method. The activity of the anti-oxidant elevated due to the activity of the free radicals in 1, 1-Diphenyl-2-picryl-hydrazyl (DPPH), nitric and super oxide. Scavenge is achieved by alkaline DMSO and lipid per oxidation method, While anti mutagenic activity were assessed by mitotic index (MI), chromosomal aberration (CA) and Micronuclei (MN,) tests. The outcomes data from the current work shows fortified honey had a highest antioxidant activity in compare with Curcuma longa extract of genotoxic activity showed that furfural increased formations of MNs, CA and MI in blood culture associated with control, opposing, fortified honey by itself didn’t display any effect in geno-toxic while the effect in anti-mutagenic of honey could be related the capability of scavenge power to antioxidant for free radical. Fortified honey reduced the mitotic index in all actions.


Alvarez-Suarez JM, Giampieri F, Battino M. 2013. Honey as a source of dietary antioxidants: Structures, bioavailability and evidence of protective effects against human chronic diseases. Current journal in Medicinal Chemistry, 20, 621–638.

Bogdanov S, Jurendic, T, Sieber R, Gallmann, P. 2008. Honey for nutrition and health: A review.  American Journal of Collision and Nutrition, 27, 677–689.

Alvarez-Suarez JM, Tulipani S, Romandini S, Bertoli E, Battino M. 2010.Contribution of honey in nutrition and human health: Mediterranean Journal of Nutrition and Metabolism3, 15–23.

Orhan F, Sekerel BE, Kocabas CN, Sackesen C, Adaliog˘lu G, Tuncer A. 2003. Complementary and alternative medicine in children with asthma. Annals of Allergy, Asthma & Immunology,90(6), 611-615.

Schramm DD, KarimM, SchraderHR,Holt RR,Kirkpatrick NJ, Polagruto JA,Ensunsa JL, 

SchmitzHH, Keen CL. 2003.Food effects on the absorption and pharmacokinetics of cocoa flavanols. Life Science , 73, 857–869.

Keen CL. 2003. Honey with high levels of antioxidants can provide protection to healthy human subjects. Journal of Agricultural Food Chemistry, 51, 1732–173.

Srivastava KC, Bordia A, Verma SK. 1995.Curcumin, a major component of food spice tumeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets.  prostaglandins leukot essent fatty acids,52, 223-227.

Zhang J, Qi H, Wu C. 2004.Research of anti-proliferation of curcumin on A549 human lung cancer cells and its mechanism. Zhongyaocai = Journal of Chinese medicinal materials, 27(12), 923-927.

Al-Mamary M, Al-Meeri A, Al-Habori M. 2002.Antioxidant activities and totalphenolics of different types of honey. Nutr Res, 22, 1041–1047.

Evans HJO’Riordan ML.1975. Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. Mutat Res, 31(3), 135-48.

Kilbey BJ, Legator M, Nichols W, Ramel C. 1984. Handbook of Mutagenicity Test Procedures. Elsevier Science Publishers, Amsterdam, 405–427 p.

Yavuz-Kocaman A, Rencuzogullari E, Ila HB, Topaktas M. 2008. The genotoxic effect of potassium metabisulfite using chromosome aberration, sister chromatid exchange, micronucleus tests in human lymphocytes and chromosome aberration test in bone marrow cells of rats. Environmental and Molecular Mutagenesis.49, 276–282.

Speit G, Houpter S. 1985.On the mechanisms of differential giemsa staining of bromodeoxyuridine-substituted chromosomes. II. Differences between the demonstrations of sister-chromatid differentiation and replication patterns. Human Genetics. 70, 126–129.

Schneider EL, Nakanishi Y, Lewis J, Sternberg H. 1981. Simultaneous examination of sister-chromatid exchanges and cell replication kinetics in tumor and normal cells in vivo. Cancer Research.41, 4973–4975.

Fenech M. 2000.The in vitro micronucleus technique.Mutation Research. 455, 81– 95.

Surrales J, Xamena N, Creus A, Catalan J, Norppa H, Marcos R. 1995.Induction of micronuclei by five pyrethroid insecticides in whole blood and isolated human lymphocytes cultures. Mutation Research.341, 169–184.

Wang H, Rosidi B, Perrault R, Wang M, Zhang L, Windhofer F, Iliakis G. 2005.DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Research. 65, 4020 4030.

Aldecott KW, McKeown CK, Tucker JD, Ljungquist S, Thompson LH. 1994. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Molecular and Cellular Biology. 14, 68–76.

Hagmar L, Brogger A, Hansteen IL, Heim S, Hogstedt B, Knudsen L, Lambert, B, Linnainmaa K, Mitelman F, Nordenson I, Reuterwall C, Salomaa SI, Skerfving S, Sorsa M. 1994. Cancer risk in human predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Research.54, 2919–2922.

Mamur S, Yuzbas_ıog˘lu D, Unal F, Yılmaz S. 2010. Does potassium sorbate induce genotoxic or mutagenic effects in lymphocytes? Toxicology In Vitro 24, 790–794.  Michaelsson, G., Juhlin, L., 1973. Urticaria induced by preservatives and dye additives in foods and drugs. British Journal Dermatology.88, 525–532.

Liou SH, Chen YH, Loh CH, Yang T, Wu TN, Chen CJ, Hsieh LL. 2002. The association between frequencies of mitomycin C-induced sister-chromatid exchange and cancer risk in arseniasis. Toxicology Letters.129, 237–243.

Gisselsson D. 2001. Chromosomal instability in cancer: causes and consequences. Atlas of Genetics and Cytogenetics in Oncology and Haematology.

Inoue A, Yokomori K, Tanabe H, Mizusawa H, Sofuni T, Hayashi Y, Tsuchida Y, Shimatake H.1997. Extensive genetic heterogeneity in the neuroblastoma cell line NB(TU)1. International Journal of Cancer 72, 1070–1077.

Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DEG Tice, Waters MD, Aitio A. 2000. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutation Research.463, 111–172.